Walter E. Aulitzky

7.6k total citations
121 papers, 3.6k citations indexed

About

Walter E. Aulitzky is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Walter E. Aulitzky has authored 121 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 40 papers in Oncology and 36 papers in Molecular Biology. Recurrent topics in Walter E. Aulitzky's work include Chronic Myeloid Leukemia Treatments (31 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Acute Myeloid Leukemia Research (22 papers). Walter E. Aulitzky is often cited by papers focused on Chronic Myeloid Leukemia Treatments (31 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Acute Myeloid Leukemia Research (22 papers). Walter E. Aulitzky collaborates with scholars based in Germany, Austria and United States. Walter E. Aulitzky's co-authors include Heiko van der Kuip, Justus Duyster, Simon Heine, Moshe Oren, Kathrin Böpple, Markus Kleih, Christian Peschel, Frank Eßmann, Meng Dong and Cornelius Miething and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Walter E. Aulitzky

119 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walter E. Aulitzky Germany 34 1.4k 1.1k 1.1k 692 502 121 3.6k
Hetty E. Carraway United States 35 1.7k 1.3× 1.4k 1.3× 1.1k 1.0× 815 1.2× 488 1.0× 212 3.6k
Junya Kuroda Japan 34 2.0k 1.5× 1.3k 1.2× 1.5k 1.4× 707 1.0× 950 1.9× 217 4.7k
Rose Ann Padua United Kingdom 32 1.6k 1.2× 1.2k 1.1× 926 0.9× 464 0.7× 480 1.0× 104 3.1k
Marco Danova Italy 30 1.1k 0.8× 553 0.5× 1.6k 1.5× 413 0.6× 520 1.0× 226 3.5k
Nelly Robillard France 34 1.6k 1.1× 1.7k 1.6× 1.2k 1.1× 641 0.9× 1.1k 2.1× 94 3.8k
Kylie D. Mason Australia 18 2.4k 1.8× 908 0.8× 809 0.8× 588 0.8× 948 1.9× 58 4.0k
Lothar Bergmann Germany 39 2.1k 1.5× 1.4k 1.3× 1.4k 1.3× 662 1.0× 1.0k 2.1× 182 4.8k
Ronan Swords United States 27 1.8k 1.3× 1.1k 1.0× 655 0.6× 464 0.7× 226 0.5× 115 3.0k
Bayard Clarkson United States 22 1.5k 1.1× 1.9k 1.7× 1.8k 1.6× 1.1k 1.6× 538 1.1× 43 4.9k
John F. Lyons United States 32 2.7k 2.0× 577 0.5× 1.3k 1.2× 321 0.5× 347 0.7× 81 4.3k

Countries citing papers authored by Walter E. Aulitzky

Since Specialization
Citations

This map shows the geographic impact of Walter E. Aulitzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter E. Aulitzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter E. Aulitzky more than expected).

Fields of papers citing papers by Walter E. Aulitzky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter E. Aulitzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter E. Aulitzky. The network helps show where Walter E. Aulitzky may publish in the future.

Co-authorship network of co-authors of Walter E. Aulitzky

This figure shows the co-authorship network connecting the top 25 collaborators of Walter E. Aulitzky. A scholar is included among the top collaborators of Walter E. Aulitzky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter E. Aulitzky. Walter E. Aulitzky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Dang, Bernhard Gillissen, Walter E. Aulitzky, et al.. (2024). BCL-2 and BOK regulate apoptosis by interaction of their C-terminal transmembrane domains. EMBO Reports. 25(9). 3896–3924. 7 indexed citations
2.
Aylon, Yael, Noa Furth, Giuseppe Mallel, et al.. (2022). Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis. Nature Communications. 13(1). 7199–7199. 5 indexed citations
3.
Weller, Sandra, Kathrin Böpple, Ute Hofmann, et al.. (2022). The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA. Cell Death Discovery. 8(1). 215–215. 21 indexed citations
4.
Arandkar, Sharathchandra, Noa Furth, Nishanth Belugali Nataraj, et al.. (2018). Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features. Proceedings of the National Academy of Sciences. 115(25). 6410–6415. 93 indexed citations
5.
Heine, Simon, Michael A. Dengler, Markus Kleih, et al.. (2017). Cyclin D1 Driven CDK4 Activity Is Responsible for Hypersensitivity to NOXA Inducing Combination Treatment in Mantle Cell Lymphoma (MCL) Cells. Blood. 130. 2811–2811. 1 indexed citations
6.
Schwab, Matthias, Christoph Ulmer, Simon Heine, et al.. (2016). Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest. Cancer Research. 76(10). 2868–2875. 60 indexed citations
7.
Gutekunst, Matthias, Thomas Mueller, Michael A. Dengler, et al.. (2013). Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4. Cancer Research. 73(5). 1460–1469. 47 indexed citations
8.
Dong, Meng, Godehard Friedel, Andreas Grabner, et al.. (2012). Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin. Cancer Research. 72(22). 5824–5832. 24 indexed citations
9.
10.
Cramer, Kimberly, Margaret Nieborowska-Skorska, Mateusz Koptyra, et al.. (2008). BCR/ABL and Other Kinases from Chronic Myeloproliferative Disorders Stimulate Single-Strand Annealing, an Unfaithful DNA Double-Strand Break Repair. Cancer Research. 68(17). 6884–6888. 74 indexed citations
11.
Kuip, Heiko van der, Thomas E. Mürdter, Maike Sonnenberg, et al.. (2006). Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC Cancer. 6(1). 86–86. 85 indexed citations
12.
13.
Schüler, Martin, Christian Peschel, Folker Schneller, et al.. (1996). Immunomodulatory and Hematopoietic Effects of Recombinant Human Interleukin-6 in Patients with Advanced Renal Cell Cancer. Journal of Interferon & Cytokine Research. 16(11). 903–910. 11 indexed citations
14.
Aulitzky, W. E., Walter E. Aulitzky, Julie A. Ellerhorst, et al.. (1995). Intermittent Low-Dose IFN Gamma Treatment for Metastatic Renal Cell Carcinoma: Analysis of Factors Predicting Clinical Response and Long-Term Survival. Oncology Research and Treatment. 18(4). 339–345. 2 indexed citations
15.
Aulitzky, Walter E., H. Grosse‐Wilde, Ulrike Westhoff, et al.. (1991). Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-γ). Clinical & Experimental Immunology. 86(2). 236–239. 43 indexed citations
16.
Schröcksnadel, H., et al.. (1990). Bilateral breast tumours in acute lymphatic leukemia. Archives of Gynecology and Obstetrics. 247(1). 43–45. 6 indexed citations
17.
Aulitzky, Walter E., Günther Gastl, Beate Lanske, et al.. (1989). Acute Effects of Single Doses of Recombinant Interferon-γ on Blood Cell Counts and Lymphocyte Subsets in Patients with Advanced Renal Cell Cancer. Journal of Interferon Research. 9(4). 425–433. 17 indexed citations
18.
Aulitzky, Walter E., Herbert Tilg, Manfred Herold, et al.. (1988). Enhanced Serum Levels of β-2-Microglobulin, Neopterin, and Interferon-γ in Patients Treated with Recombinant Tumor Necrosis Factor-α. Journal of Interferon Research. 8(5). 655–664. 12 indexed citations
19.
Gastl, Günther, et al.. (1986). Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing. Annals of Hematology. 52(5). 273–279. 19 indexed citations
20.
Frick, J., Walter E. Aulitzky, Dietmar Fuchs, et al.. (1985). The Value of Urinary Neopterin as an Immunological Parameter in Patients with Malignant Tumors of the Genitourinary Tract. Urologia Internationalis. 40(3). 155–159. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hetty E. Carraway Breakdown of academic impact, for papers by Junya Kuroda Breakdown of academic impact, for papers by Rose Ann Padua Breakdown of academic impact, for papers by Marco Danova Breakdown of academic impact, for papers by Nelly Robillard Breakdown of academic impact, for papers by Kylie D. Mason Breakdown of academic impact, for papers by Lothar Bergmann Breakdown of academic impact, for papers by Ronan Swords Breakdown of academic impact, for papers by Bayard Clarkson Breakdown of academic impact, for papers by John F. Lyons
Rankless by CCL
2026